AKYLA
Equity Research
Semiconductors & Related Devices — Optical/Photonics
Initiation of Coverage — BUY
Last Updated: June 28, 2026
POET Technologies Inc. (POET)
Optical-interposer photonics levered to the AI interconnect boom; pre-revenue today, with a credible, execution-gated path to ~2x by mid-2028 as the Malaysia line ships and the Lumilens PO converts.
Thesis
- POET sits directly in the path of the AI optics super-cycle. AI optical transceiver TAM is modeled to jump from ~$16.5B (2025) to ~$26B (2026), with >800G unit shipments rising ~2.6x (24M -> 63M units) and demand running ~30% ahead of supply. POET's wafer-level Optical Interposer is a manufacturing-cost wedge into exactly this shortage.
- The wedge is now commercial, not conceptual. A Lumilens supply agreement carries a $50M initial purchase order within a framework management frames as $500M+ over five years; a Foxconn Interconnect Technology design win places POET engines into 800G/1.6T modules; and the company guides to shipping 'more than 30,000 optical engines this year' — light-source product from Q2 and 800G engines from Q3 off the Globetronics/Malaysia line (~1M engines/yr capacity).
- The EML laser shortage is POET's tailwind. NVIDIA pre-allocated a large share of EML capacity with lead times stretched beyond 2027, and 800G production may fall 40-60% short of demand through 2027. POET's light-source products and the POET-Sivers Gen-3 CPO+ELS module (prototypes H1 2026, production-ready end-2026) target precisely this gap.
- Balance sheet de-risks the ramp. Post the May 2026 $400M registered direct offering, pro-forma cash exceeds $400M against ~$8.8M/quarter cash burn — multi-year runway. The near-term risk is execution and dilution, not liquidity.
- PATH TO 2x (by mid-2028): pre-revenue today re-rates as the Malaysia line ships and the Lumilens PO converts. Bridge: ~$120M normalized 2027-28 product revenue (30k+ engines scaling into the $50M Lumilens PO and FIT volumes) x a ~28x P/S — a discount to the re-rated optical peer set (AAOI +390%, MRVL +228%, LITE +138% YTD) given POET's earlier stage — = ~$3.4B market cap, roughly 2x today's ~$1.64B and ~$19/share. Explicitly execution-gated; we size it off unit guidance x ASP below.
- Headline short-seller risk has faded. The Night Market Research report alleging dormant partnerships was largely disproven as the Lumilens and Foxconn relationships advanced — we treat it as a refuted risk to diligence, not a thesis-breaker.
Disclaimer
This is not financial advice.
This report is for informational purposes only and is not investment advice. POET is a foreign private issuer; figures are as-reported in USD from company filings, IR releases and web-sourced dossier items (not the SEC-XBRL financials terminal). Forward product-revenue lines are analyst estimates explicitly gated on execution of the Malaysia production ramp and conversion of named purchase orders; they are not guaranteed. Akila Advisory holds a constructive (long) house view.